Name: Seema Tiwari-Woodruff
Affiliation: Professor of Biomedical Sciences
Division of Biomedical Sciences
University of California, Riverside

Dr. Tiwari-Woodruff has a MS in Chemistry and a PhD in Physiology from Southern Illlinois University at Carbondale, Ill. After completing a post-doctoral fellowship in the Neurology Department at UCLA, Dr. Tiwari-Woodruff was made a member of the faculty where she served until 2014. She is presently an Associate Professor and Graduate Student Advisor with the Division of Biomedical Sciences in the School of Medicine at UCRat Riverside, CA. The Tiwari-Woodruff lab investigates mechanisms of demyelination-induced neurodegeneration, myelination sex differences and therapeutic neuroprotection using two demyelinating mouse models of MS: immune-mediated experimental autoimmune encephalomyelitis (EAE) and non-immune-mediated toxic cuprizone diet. Additionally, through continued collaborations with researchers at UIUC, UCLA, and pharmaceutical companies, the lab interrogates therapeutic efficacies and mechanisms of action of various approved and potential MS drugs. She currently holds a patent for the use of a novel class of estrogen receptor agonists as remyelinating drug. Dr. Tiwari-Woodruff has has been actively engaged in American Society of Neuroschemistry-ASN/International Scociety of Neurochemistry-ISN programming and governance at several levels. Since her election in 2017, Dr. Tiwari-Woodruff has served as secretary of the ASN.